(N-(2-methyloxy-5-(2',4',6'-trimethoxystyrylsulfonyl)methylenephenyl)amino)acetic acid,
N-(2-Methoxy-5-((((E)-2-(2,4,6-trimethoxyphenyl)vinyl)sulfonyl)methyl)phenyl)glycine,
ON 01910,
ON 01910.Na,
ON-01910,
ON01910,
rigosertib,
rigosertib sodium,
sodium (N-(2-methyloxy-5-(2',4',6'-trimethoxystyrylsulfonyl)methylenephenyl)amino)acetate,
Rigosertib,
592542-59-1,
UNII-67DOW7F9GL,
67DOW7F9GL,
N-[2-Methoxy-5-({[(E)-2-(2,4,6-Trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine,
ON-01910.Na,
Rigosertib [USAN:INN],
6FS,
Rigosertib (USAN),
AC1OCFT5,
Estybon (proposed trade name),
SCHEMBL498623,
SCHEMBL498624,
GTPL7833,
CHEMBL1241855,
ON01910.Na,
DTXSID30207984,
CHEBI:124939,
OWBFCJROIKNMGD-BQYQJAHWSA-N,
1910 Na,
BCP08296,
ZINC3942646,
4006AH,
BDBM50060917,
AKOS015966442,
DB12146,
SB16468,
(E)-2-((2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)phenyl)amino)acetic acid,
2-[[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]phenyl]amino]acetic Acid,
AS-35249,
AB0107341,
D10154,
ON-01910;ON01910;ON 01910,
BRD-K55187425-236-01-1,
(e)-2-(5-((2,4,6-trimethoxystyrylsulfonyl)methyl)-2-methoxyphenylamino)acetic acid,
2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetic acid,
N-(2-Methoxy-5-((((1E)-2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl)methyl) phenyl)glycine,
N-[2-Methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]glycine,
Glycine, N-(2-methoxy-5-((((1E)-2-(2,4,6-trimethoxyphenyl)ethenyl)sulfonyl) methyl)phenyl)-,
Glycine, N-[2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]phenyl]-,
ON-01910|||2-[2-Methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetic acid,
Rigosertib [USAN],
D0KF9Q,
C21H25NO8S,
ON-01910,
CID6918736,
ON 01910,
B1288,